VAERS 2147467
SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ571AA
- Staat
- MI
- Alter
- 0,2
- Geschlecht
- M
- Eingang
- 27.02.2022
- Impfdatum
- 12.10.2021
- Beginn
- 12.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LL
Symptomtext
incomplete dose administered; Initial information received on 21-Feb-2022 regarding an unsolicited valid non-serious case received from a other health professional via call center. This case involves a 2 months old male patient who experienced incomplete dose administered while receiving vaccine diphtheria/tetanus/5 hybrid ac pertussis/IPV(MRC5)/HIB(PRP/T) vaccine [Pentacel]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included pneumococcal vaccine CONJ 7V (CRM197) (Prevnar) and rotavirus vaccine (Rotavirus vaccine) for Immunization. On 12-Oct-2021, the patient received a first 0.5 ml dose of suspect diphtheria/tetanus/5 hybrid ac pertussis/IPV(MRC5)/HIB(PRP/T) vaccine lot UJ571AA via unknown route in the left thigh (dosage form, strength, formulation and expiry date: unknown). On 21-Feb-2022 he also received a second 0.5 ml dose of the same vaccine lot UJ527AA via unknown route in the left thigh (dosage form, strength, formulation and expiry date: unknown) for immunization. On 12-OCT-2021, the patient developed a non-serious event incomplete dose administered (incorrect dose administered) (latency: same day) following the administration of diphtheria/tetanus/5 hybrid ac pertussis/IPV(MRC5)/HIB(PRP/T) vaccine. Action taken: Not applicable. It was not reported if the patient received a corrective treatment for the event (incomplete dose administered). At time of reporting, the outcome was Unknown for the event incomplete dose administered. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -